pacific
biosciences
announces
new
chief
financial
officer
menlo
park
globe
newswire
pacific
biosciences
california
nasdaq
pacb
leading
provider
sequencing
genomes
transcriptomes
epigenomes
today
announced
appointment
susan
kim
chief
financial
officer
effective
september
delighted
susan
joining
company
time
many
opportunities
drive
growth
said
christian
henry
recently
appointed
chief
executive
officer
pacific
biosciences
susan
deep
experience
aspects
financial
operations
help
drive
execution
susan
also
highly
capable
leader
managed
growth
large
small
organizations
welcome
addition
management
kim
stated
honored
working
christian
entire
pacific
biosciences
team
accelerate
growth
deliver
value
kim
brings
twenty
plus
years
finance
operations
experience
pacific
biosciences
recently
served
chief
financial
officer
app
annie
katerra
leading
technology
companies
roles
susan
instrumental
driving
revenue
growth
scaling
finance
operations
realizing
synergies
strategic
acquisitions
course
kim
career
held
variety
leadership
roles
global
dollar
public
companies
including
kla
corporation
morgan
stanley
advanced
micro
devices
kim
earned
master
engineering
management
kellogg
school
management
northwestern
university
chemical
engineering
stanford
university
kim
recognized
one
influential
women
bay
area
business
san
francisco
business
times
pacific
biosciences
pacific
biosciences
california
nasdaq
pacb
empowering
life
scientists
highly
accurate
sequencing
company
innovative
instruments
based
single
molecule
sequencing
technology
delivers
comprehensive
view
genomes
transcriptomes
epigenomes
enabling
access
full
spectrum
genetic
variation
organism
cited
thousands
publications
sequencing
systems
use
scientists
around
world
drive
discovery
human
biomedical
research
plant
animal
sciences
microbiology
statements
statements
press
release
historical
statements
including
among
things
statements
relating
plans
growth
success
commencement
employment
new
chief
financial
officer
future
events
place
undue
reliance
statements
involve
known
unknown
risks
uncertainties
changes
circumstances
factors
cases
beyond
pacific
biosciences
control
could
cause
actual
results
differ
materially
information
expressed
implied
statements
made
press
release
factors
could
materially
affect
actual
results
found
pacific
biosciences
recent
filings
securities
exchange
commission
including
pacific
biosciences
recent
reports
forms
include
listed
caption
risk
pacific
biosciences
undertakes
obligation
revise
update
information
press
release
reflect
events
circumstances
future
even
new
information
becomes
available
